The American Association for Cancer Research (AACR) has honored GSBS faculty member Karen Lu, MD, chair of Gynecologic Oncology and Reproductive Medicine at The University of Texas MD Anderson Cancer Center, as one of the inaugural recipients of the Victoria’s Secret Global Fund for Women’s Cancers 2022 Meritorious Awards, In Partnership with Pelotonia & AACR.

The Victoria’s Secret Global Fund for Women’s Cancers Meritorious Awards, in Partnership with Pelotonia and AACR, are intended to foster innovative research aimed at transforming outcomes for breast and gynecologic cancers, while also serving as an investment in the next generation of female cancer researchers worldwide. Lu was selected for her significant contributions in the field of hereditary gynecologic cancers and in the prevention and early detection of endometrial and ovarian cancers.

Her work over the past 25 years has progressed the care of women with a genetically increased risk of ovarian and endometrial cancers, and she is a leader in defining management of ovarian cancer risk in women with BRCA1 and BRCA2 mutations. Lu is affiliated with the GSBS Cancer Biology Program and the co-medical director of the Clinical Cancer Genetics Program at MD Anderson. As a researcher, she has contributed to multiple advancements in the treatment of hereditary gynecologic cancers, including:

• 开创了子宫内膜癌和林奇综合征的研究，该研究发表了多次开创性的风险，筛查和预防策略研究，从而定义了针对林奇综合征女性的国际护理标准
• Directed the largest high-risk ovarian cancer screening study, which defined the CA-125 cut point that needed customization based on menopausal status for women at high risk to develop the disease
• Provided one of the first reports of microscopic fallopian tube cancers in women who carryBRCAmutations
• Led national studies aiming to decrease barriers to genetic testing and to develop novel prevention strategies for women at increased risk for ovarian cancer, based on the fallopian tube origin ofBRCA- 相关的卵巢癌。LED建立了两个国家准则变更BRCA对所有卵巢通过测试r patients as the standard of care

除研究和临床护理外，LU还担任了一代妇beplay苹果手机能用吗科肿瘤学研究员，博士后研究员和学生的研究导师。她对培训下一代领导者的承诺在她领导的多个计划中得到了强调，其中包括美国国立卫生研究院T32妇科肿瘤学培训计划。作为国家癌症研究所资助的专业研究卓越专业计划（SPORE）的主要研究者，她开发了基于团队的子宫内膜癌的转化研究，并为子宫内膜癌症研究提供了资助的年轻研究者。beplay苹果手机能用吗

“It is an incredible honor to be selected for this award, which recognizes the work to improve the lives of women with gynecologic cancers,” Lu said. “I continue to be inspired by the next generation of clinicians and research scientists that are contributing to what we know about gynecologic cancers.”